PHVS Overview

Company Profile

Related stocks

ASND • Denmark

Ascendis Pharma A/S

229.23 USD

15.08B USD 1Y +6%

9606.HK • China

DUALITYBIO-B

182.7 HKD

2.13B USD 1Y -42.1%

PVLA • United States

Palvella Therapeutics, Inc.

138.77 USD

2B USD 1Y +75.5%

GENB • United States

Generate Biomedicines, Inc.

14.34 USD

1.84B USD

SEPN • United States

Septerna, Inc.

38.37 USD

1.79B USD 1Y +64.1%

ONESOURCE.NS • India

ONESOURCE SPECL PHARMA L

1,461.3 INR

1.73B USD 1Y -22.7%

MAZE • United States

Maze Therapeutics, Inc.

27.11 USD

1.51B USD 1Y -9.5%

KLRA • United States

Kailera Therapeutics, Inc.

11.61 USD

1.51B USD

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

177.1% p.a.

Max Drawdown (5Y)

-92.8%

Sharpe Ratio (5Y)

0.07

Beta Factor

-2.46

Size Class

Mid Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (177.1% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -92.8% in the extended horizon.